Anderson Kenneth Carl (CIK 1824862) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy CCCC (2,650 shares), Buy CCCC (4,259 shares), Buy CCCC (5,958 shares), Buy CCCC (5,349 shares), Buy CCCC (7,616 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | C4 Therapeutics, Inc. (CCCC) | Director | Buy | 2,650 | $11,501 |
| 2026-04-03 | C4 Therapeutics, Inc. (CCCC) | Director | Buy | 4,259 | $11,499 |
| 2026-01-05 | C4 Therapeutics, Inc. (CCCC) | Director | Buy | 5,958 | $11,499 |
| 2025-10-03 | C4 Therapeutics, Inc. (CCCC) | Director | Buy | 5,349 | $11,500 |
| 2025-07-02 | C4 Therapeutics, Inc. (CCCC) | Director | Buy | 7,616 | $11,500 |
| 2025-04-03 | C4 Therapeutics, Inc. (CCCC) | Director | Buy | 7,841 | $11,291 |
Source: SEC Form 4 filings · as of 2026-07-02